The American Family Children’s Hospital (AFCH) is a $100 million facility located in Madison, WI which provides world-class medical care to children and young adults in a comforting and friendly environment. The 111-bed facility was constructed in 2007 and houses a level 1 trauma center, surgical pavilion, pediatric sedation program, nationally recognized transplant program, and a Children’s Cancer Center which includes an 131I-MIBG treatment suite. AFCH employs 262 physicians and is part of UW Health, the integrated health system of the University of Wisconsin School of Medicine and Public Health, which ranks among the finest academic medical centers in the United States. AFCH is also part of the University of Wisconsin Carbone Comprehensive Cancer Center (UWCCC), the only NCI-designated cancer center in the state of Wisconsin. UWCCC encompasses approximately 390,000 square feet of contiguous space which includes the Wisconsin Institute for Medical Research and the McArdle Research Laboratories, and provides consultation, treatment, and follow-up care for 30,000 patients annually.

The Division of Pediatric Hematology, Oncology and Bone Marrow Transplant provides compassionate, state-of the art, family-centered care to children and young adults with a wide variety of oncologic, hematologic and vascular disorders. The Division includes 10 board-certified pediatric hematologists/oncologists, 3 advanced practice nurses, 6 clinical research associates and a research RN. Our program is ranked by USNWR, and has been designated 1 of 10 U.S. Centers of Excellence for the treatment of neuroblastoma. Our faculty are active members of the UWCCC, the Program for Advanced Cellular Therapy (a GMP facility), and the Wisconsin Blood Cancer Research Institute. Our faculty’s clinical and translational research programs are focused on the development of novel CAR T cell, monoclonal antibody, and ex-vivo activated/expanded natural killer cell therapies. We are also investigating the combined use of immunotherapy and molecular-targeted radiotherapeutics, such as 131I-MIBG and 90Y-NM600.

Dr. Richards is the POETIC site PI from the University of Wisconsin-Madison, where she is an Assistant Professor in the Division of Pediatric Hematology, Oncology, and Bone Marrow Transplant. She completed her Residency in Pediatrics at Seattle Children’s Hospital/University of Washington, and her Fellowship in Pediatric Hematology/Oncology at Stanford University. Her clinical focus includes high-risk leukemia, immunotherapy, and bone marrow transplant. She runs a research lab with a focus on developing CAR T cells for patients with acute myeloid leukemia, and is passionate about translating these discoveries to the clinic so more patients can benefit from immunotherapies. She is part of the Immunotherapy Working Group within POETIC.

Dr. Stuckert is the POETIC site co-PI from the University of Wisconsin-Madison, where she is an Assistant Professor in the Division of Pediatric Hematology, Oncology, Transplant and Cellular Therapy. She earned her medical degree from the Medical College of Wisconsin and completed her Pediatrics Residency and Fellowship at Baylor College of Medicine / Texas Children’s Hospital. Her clinical and research focus is in Pediatric Central Nervous System tumors and immunotherapy. She is part of the Neuro-Oncology Working Group and the Immunotherapy Working Group within POETIC.